Subsidies & Funding

We empower medical innovation

Project Management

We manage research & innovation projects

Business Strategy

We support successful commercialisation

Christopher Haggarty-Weir, PhD, MBA Consultant

Christopher holds a Universitas 21 joint PhD in medicine and biophysical chemistry from the University of Melbourne's Faculty of Medicine (Walter and Eliza Hall Institute) and the University of Edinburgh (the Joseph Black School of Chemistry). His research focused on anti-malarial drug and vaccine development, aiming to help a potential therapeutic into pre-clinical development under the supervision of Prof. Alan Cowman (WEHI and Harvard Medical School). After his PhD he obtained an MBA in finance & management, with a focus on biopharma M&A deals.

Christopher has experience in bioscience business development, biopharma venture capital, and served as the COO of a Scottish biotech company focused on drug screening. He founded his own life science consultancy, Haggarty-Weir Consulting, that grew to a team of six, serving clients such as UCB Biopharma and Mercia Capital. He now serves as a professional advisor at MIT and has joined ttopstart in 2020 as a life science and healthcare consultant.

More information


Christopher Haggarty-Weir, PhD, MBA
+31 (0) 682 622 428